Position in IONS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,936,426
+$3,680,368 QoQ
Shares Held
226,213
+19.2% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 513 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. IONS ranks #14 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in IONS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,936,426 | 226,213 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $14,256,058 | 189,853 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $22,154,358 | 280,045 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $18,663,866 | 285,293 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,291,449 | 209,857 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,730,547 | 256,233 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,572,072 | 331,009 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $13,706,687 | 342,154 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $17,470,296 | 366,561 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $25,323,247 | 584,158 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $30,063,106 | 594,250 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $28,029,303 | 617,930 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $25,146,915 | 612,891 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $22,378,600 | 626,150 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $22,965,670 | 608,040 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $30,513,036 | 689,872 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $26,802,293 | 723,995 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $31,198,198 | 842,284 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $24,677,693 | 810,966 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $28,622,028 | 853,370 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $33,564,680 | 841,431 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $52,018,673 | 1,156,999 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $65,061,593 | 1,150,718 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $43,560,379 | 918,027 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $57,040,792 | 967,449 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $45,733,610 | 967,293 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||